CRDF NASDAQ
Cardiff Oncology, Inc.
1W: +3.5%
1M: +3.5%
3M: +11.2%
YTD: -32.7%
1Y: -41.7%
3Y: +5.3%
5Y: -79.1%
$1.78
-0.01 (-0.56%)
Weekly Expected Move ±8.2%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
-10.7% YoY
$-45M
Net Income
+8.4% YoY
$-37M
Free Cash Flow
+12.4% YoY
-439.0%
Gross Margin
-31341.5%
Op. Margin
-30124.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-69.8%
ROA-56.3%
ROIC310.1%
Valuation
P/E-2.6
P/B3.3
EV/EBITDA-1.2
Leverage
Debt/Equity0.02
Current Ratio3.67
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-7.34
Beneish M-0.65